![](http://storage0.dms.mpinteractiv.ro/media/401/1561/19649/22378518/1/poza-medicamente.jpg?width=160&height=120)
Drugmaker Zentiva (SCD.RO), held by Prague-based Zentiva Group, reported net profit of RON74.2 million for the first quarter of 2024, compared to RON42.7 million in the same period of 2023, and a turnover of RON266 million, from RON230 million in the first quarter of 2023, as per its quarterly financial report published at the Bucharest Stock Exchange.